Retatrutide, by Soma Pharmaceuticals , is attracting increasing attention as a innovative therapy for weight regulation. This unique medication integrates the activity of a GLP-1 receptor stimulant and check here a GIP receptor activator , designed to not only promote weight loss but also target associated metabolic factors. Initial patient data ha